GHRH(1-29) Analog
Sermorelin stimulates the pituitary gland to release growth hormone, which can raise IGF-1. It is claimed to improve sleep, recovery and body composition.
Sermorelin copies the part of growth-hormone-releasing hormone that tells the pituitary gland to release growth hormone. Growth hormone can then raise IGF-1, a signal involved in growth and tissue maintenance. Sermorelin is claimed to improve muscle, recovery, sleep, fat loss and aging, but raising a hormone level does not prove that adults experience those benefits. [1,2,3]
Function evidence: Known hormone-release action; claimed adult benefits unproven
Adults are often promised better sleep, more muscle, easier fat loss, faster recovery or a more youthful sense of energy. Sermorelin can stimulate growth-hormone release, but that hormone change does not establish those day-to-day outcomes. Historical Geref products were used in specified pediatric growth-hormone deficiency and diagnostic settings. Those uses do not validate broad adult anti-aging protocols, and the cited literature does not provide a controlled demonstration that otherwise healthy adults look, feel or perform better. [1,2,3]
What supports this description: Known hormone response; broad adult wellness outcomes not established
Dose: No consumer dose is established or recommended here. | Frequency: No routine treatment schedule established. | Cycle: No validated consumer cycle. | Route: No routine patient route established.
Preparation: No patient reconstitution recipe. Trial preparation is not a recommendation..
Sermorelin is an analogue of growth-hormone-releasing hormone. FDA previously approved Geref products, which were later discontinued for reasons unrelated to safety or effectiveness. That history does not amount to an approval for adult anti-aging, muscle gain, sleep or fat-loss treatment. The sources reviewed here identify no sermorelin product that is currently FDA-approved. [1,2]
Specific Geref products had historical approvals. FDA later determined their discontinuation was not for safety or effectiveness reasons. That does not mean current compounded sermorelin is FDA-approved. [1]
Adequate evidence for those claimed adult outcomes and routine combinations is not established here. [1,2]
Historical diagnostic/pediatric product; claimed adult uses unestablished. Sermorelin is an analogue of growth-hormone-releasing hormone. FDA previously approved Geref products, which were later discontinued for reasons unrelated to safety or effectiveness. That history does not amount to an approval for adult anti-aging, muscle gain, sleep or fat-loss treatment. The sources reviewed here identify no sermorelin product that is currently FDA-approved. [1,2]
Approval status: Not FDA-approved. [1,2]
Educational evidence summary. Approval applies only to the named product and indication; compounded, investigational, and research-market products are different categories.